latest news releases from the newsroom
Berger & Montague PC
Berger & Montague, P.C. Sues on Behalf of Investors Who Purchased Dynegy, Inc. Securities Between April 17, 2001 and April 24, 2002 -- DYN
PHILADELPHIA, May 20, 2002 (PRIMEZONE) -- On May 3, 2002, the law firm of Berger & Montague, P.C. (http://www.bergermontague.com) filed a class action suit against Dynegy ("Dynegy" or the "Company") (NYSE:DYN) and certain of its principal officers and directors in the United States District Court for the Southern District of Texas on behalf of all persons or entities who purchased publicly traded securities of Dynegy between April 17, 2001 and April 24, 2002 the ("Class Period").
Aldata Solution Oyj
Aldata Signs Two G.O.L.D. Agreements with Tesco
VANTAA, Finland, May 20, 2002 (PRIMEZONE) -- Aldata will supply G.O.L.D. supply chain management software for two Tesco projects in Central Europe. In the first Tesco, one of the largest retail chains in the world, has agreed to purchase the G.O.L.D. e-Retail module and in the second, Tesco will upgrade its warehouse systems deploying the G.O.L.D. Warehouse Management System (WMS), which operates via radio frequency. The projects will bring Tesco economies of scale and raise productivity. After pilot trials the software will be distributed to Tesco's operations in the Czech Republic, Slovakia, Poland and Hungary.
ukbetting plc Plays Its Hand at Poker; Poker Zone to Launch at Star-Studded London Poker Night
LONDON, May 20, 2002 (PRIMEZONE) -- ukbetting plc is today launching a poker news and information website, www.pokerzone.co.uk. The Poker Zone forms part of the recently launched betting information website, www.bettingzone.co.uk and is being launched in conjunction with the ukbetting sponsored London Poker Night on Monday, May 20. The night is expected to attract the glitterati of the London poker scene and players will include Ben Elliot, Zac Goldsmith and Tom Parker Bowles amongst many others.
GeneMedix plc: Results for Quarter Ended February 28, 2002
SUFFOLK, U.K., May 20, 2002 (PRIMEZONE) -- GeneMedix plc, ("GeneMedix" or "the Company") (LSE:GMX), the U.K. generic biopharmaceutical company with operations in Europe and Asia and with joint London and Singapore Stock Exchange listings, announces its results for the 3 months to February 28, 2002. GeneMedix is involved in the development and manufacture of therapeutic proteins using recombinant DNA technology and novel cell culture.